abstract
- GIM/FP/GP: [Formula: see text] Nephrology: [Formula: see text] Rheumatology: [Formula: see text].
In active lupus nephritis, adding obinutuzumab to standard therapy increased complete renal response rates at 76 wk.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- June 2025
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Adult (MeSH)
- Antibodies, Monoclonal, Humanized (MeSH)
- Drug Therapy, Combination (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Immunosuppressive Agents (MeSH)
- Lupus Nephritis (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Remission Induction (MeSH)
published in
- ACP journal club Journal